AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Universitaire, Amiens
💬

In plain words

What the trial is, and whether it could suit you

In critical care, hemodynamic instability often requires volume expansion to restore tissue perfusion, increasing fluid balance and TBW, factors associated with higher mortality. Excess fluid leads to organ dysfunction due to venous congestion, making fluid removal crucial. When diuretics fail, RRT, typically through continuous renal replacement therapy (CRRT), is recommended. However, prescribing the correct level of UF is challenging; insufficient UF can worsen edema, while excessive UF risks hemodynamic instability. This pilot, single-center, prospective, interventional, randomized, controlled, open-label study includes two parallel groups: a standard group with UF prescribed by the physician based on clinical and hemodynamic status and an experimental group with UF guided by the extracellular to total body water (ECW/TBWat) ratio measured by BIA. The aim is to determine if ECW/TBW-gu

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age \> 18 years * The patient was hospitalized in the intensive care unit of Amiens-Picardie University Hospital. * Patient with an increase in fluid balance (TBW \> 5%) * Patient receiving continuous veno-venous hemofiltration (CVVH) on a PrismaFlexR or PrisMaxR machine, initiated due to oliguria, potassium level \> 6.5 mmol/L, urea level \> 25 mmol/L, or creatinine \> 300 µmol/L and severe metabolic acidosis (pH \< 7.2). * Hemodynamically stable patient with a mean arterial pressure (MAP) \> 65 mmHg for more than 4 hours with norepinephrine. * Signed consent to participate in the study by the patient or, if unconscious, their legal representative/next of kin. Exclusion Criteria: * Invalid BIA measurements * Internal device powered by an electrical current (pacemaker, implantable cardioverter-defibrillator, neurostimulator) * Cardiac arrhythmia (atrial fibrillation, atrial flutter) present at the inclusion * Chronic dialysis patient * Moribund patient * The patient is on extracorporeal mechanical support * Hemorrhagic shock * Pregnant woman * Patient under guardianship or conservators.
💊

What it tests

  • continuous renal replacement therapy (CRRT)
  • Free UF Prescription
📍

Where

1 site
CHRU Amiens
Salouël, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy